These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4188271)

  • 21. Phenoxybenzamine in the treatment of cardiogenic shock.
    Freeman J
    Med J Aust; 1969 Dec; 2(23):1151-4. PubMed ID: 5374054
    [No Abstract]   [Full Text] [Related]  

  • 22. [Carbohydrate tolerance, insulin secretion and insulin sensitivity in acute pancreatitis].
    Adlung J; Koch C; Ritter U
    Z Gastroenterol; 1974 Mar; 12(2):81-6. PubMed ID: 4825093
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of carbohydrate metabolism in cardiogenic stress].
    Széplaki F; Balázsi I; Stützel M; Kajbinger L; Fekete M
    Orv Hetil; 1974 Apr; 115(17):967-71. PubMed ID: 4827218
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiogenic shock developing in the coronary care unit in patients with ST-elevation myocardial infarction.
    De Luca G; Savonitto S; Greco C; Parodi G; Dajelli Ermolli NC; Silva C; Lucci D; Gonzini L; Maggioni AP; Cuccia C;
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1023-9. PubMed ID: 18799965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Insulin secretion study during arginine perfusion. Comparative effects of sympatholytics in normal subjects and hyperthyroid patients].
    Modigliani E; Strauch G; Delzant G; Gilbert-Dreyfus
    Rev Fr Etud Clin Biol; 1969 Mar; 14(3):267-75. PubMed ID: 5790135
    [No Abstract]   [Full Text] [Related]  

  • 26. [Behavior of the serum I.R.I. in persons with latent diabetes after endovenous tolbutamide load].
    Artenisio AC; Albanese MC; Allegra V; Alibrando S; Caruso A; Sprovieri M; Corsi V
    Folia Endocrinol; 1972 Aug; 25(4):300-11. PubMed ID: 4678219
    [No Abstract]   [Full Text] [Related]  

  • 27. Mode of action of a diazoxide analog (A025). Its effects on insulin secretion.
    Grant AM; Basabe JC; Lopez NL; Krees SV; Wolff FW
    Diabetes; 1970 Sep; 19(9):630-8. PubMed ID: 4990295
    [No Abstract]   [Full Text] [Related]  

  • 28. Some aspects of "acute phase" insulin release in healthy subjects.
    Siegal AM; Kreisberg RA; Owen WC; Fox OJ
    Diabetes; 1972 Mar; 21(3):157-62. PubMed ID: 5011981
    [No Abstract]   [Full Text] [Related]  

  • 29. [Insulin secretion in chronic kidney failure].
    Kokot F; Kuska J
    Z Gesamte Inn Med; 1973 Jun; 28(12):351-4. PubMed ID: 4729262
    [No Abstract]   [Full Text] [Related]  

  • 30. Biological activities of tolbutamide and its metabolites. A dissociation of insulin-releasing and hypoglycemic activity.
    Feldman JM; Lebovitz HE
    Diabetes; 1969 Aug; 18(8):529-37. PubMed ID: 5808747
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute metabolic response in myocardial infarction.
    Opie LH
    Br Heart J; 1971; 33(Suppl):Suppl:129-37. PubMed ID: 4324636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disturbances in cabohydrate metabolism at the acute stage of myocardial infarction.
    Tatoń J; Ceremuzyński L; Wiśniewska A
    Pol Med J; 1970; 9(4):787-93. PubMed ID: 5477484
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic disorders in myocardial infarction. Changes in blood serum zinc, growth hormone, insulin and glucose concentration in patients with acute myocardial infarction.
    Lewandowicz J; Komorowski JM; Goźliński H
    Cor Vasa; 1979; 21(5):305-16. PubMed ID: 397040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of tolbutamide-mediated insulin release in adult onset diabetics by methysergide maleate.
    Baldridge JA; Quickel KE; Feldman JM; Lebovitz HE
    Diabetes; 1974 Jan; 23(1):21-4. PubMed ID: 4588670
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lack of incretion of insulin in the blood in reversible cardiogenic shock].
    Mattace R; Zacà F; Bugiardini R; Puddu P; Lenzi S
    Boll Soc Ital Cardiol; 1981; 26(10):1391-4. PubMed ID: 6758811
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin response to glucose and tolbutamide in "essential" versus "pancreatic" mild glucose intolerance.
    Vague P; Ramahandridona G; Gerolami A
    Diabetes; 1974 Nov; 23(11):896-901. PubMed ID: 4430416
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin response to repeated stimuli in the aged: evidence of no exhaustion.
    Casale G; de Nicola P
    Z Alternsforsch; 1982; 37(1):23-6. PubMed ID: 7039153
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial: Metabolism and infarction.
    Br Med J; 1974 Sep; 3(5932):643. PubMed ID: 4425786
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma-insulin in coronary heart-disease: response to oral and intravenous glucose and to tolbutamide.
    Nikkilä EA; Miettinen TA; Vesenne MR; Pelkonen R
    Lancet; 1965 Sep; 2(7411):508-11. PubMed ID: 4158173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.